Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer

BACKGROUND: To evaluate the outcome of patients treated with stereotactic ablative body radiotherapy (SABR) with curative intent for stage I non-small cell lung cancer (NSCLC) with regard to local, regional and distant tumor control, disease-free survival (DFS), overall survival (OS) and toxicity. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubaere, Emilie, Goffaux, Mathilde, Wanet, Marie, Bihin, Benoit, Gheldof, Céline, Demoulin, Anne-Sophie, Bolly, Antoine, Bustin, Frederique, Duplaquet, Fabrice, Baugnee, Paul-Emile, Gustin, Michel, Hers, Vincent, Maisin, Fabienne, Marchand, Eric, Ocak, Sebahat, Pirard, Lionel, Vancutsem, Oswald, Van Neck, Evelyne, Vandermoten, Guy, Zaharia, Luminata, Remouchamps, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599378/
https://www.ncbi.nlm.nih.gov/pubmed/31253136
http://dx.doi.org/10.1186/s12885-019-5863-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599378/
https://www.ncbi.nlm.nih.gov/pubmed/31253136
http://dx.doi.org/10.1186/s12885-019-5863-2

Ejemplares similares